EXS-73565

N/A

Report date: 2026/04/07 20:00:20
NME

Base Information

Drug NameEXS-73565
Drug Alias NameEXS-73565REC-3565‘565
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMucosa-associated lymphoid tissue lymphoma translocation protein 1 inhibitors
TargetsMucosa-associated lymphoid tissue lymphoma translocation protein 1
Therapy Area/IndicationsLymphoma, B-CellNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomSpain
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRecursion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesRecursion Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsLymphoma, B-CellNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A